NPPC
Basic information
Region (hg38): 2:231921809-231926396
Links
Phenotypes
GenCC
Source:
- short stature with nonspecific skeletal abnormalities 1 (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (59 variants)
- not_specified (16 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPPC gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024409.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 8 | 2 | 11 | ||
| missense | 43 | 3 | 2 | 48 | ||
| nonsense | 3 | 3 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 49 | 11 | 4 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| NPPC | protein_coding | protein_coding | ENST00000409852 | 2 | 4584 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 123355 | 0 | 3 | 123358 | 0.0000122 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.323 | 58 | 65.3 | 0.888 | 0.00000297 | 765 |
| Missense in Polyphen | 12 | 11.941 | 1.005 | 106 | ||
| Synonymous | 0.613 | 27 | 31.4 | 0.861 | 0.00000141 | 289 |
| Loss of Function | 0.820 | 2 | 3.70 | 0.540 | 1.60e-7 | 48 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000285 | 0.0000271 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hormone which plays a role in endochondral ossification through regulation of cartilaginous growth plate chondrocytes proliferation and differentiation. May also be vasoactive and natriuretic. Specifically binds and stimulates the cGMP production of the NPR2 receptor. Binds the clearance receptor NPR3 (By similarity). {ECO:0000250, ECO:0000269|PubMed:1672777}.;
- Pathway
- Fluid shear stress and atherosclerosis - Homo sapiens (human);Physiological factors;Cardiac conduction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.241
Intolerance Scores
- loftool
- 0.517
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.25
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- ossification;response to hypoxia;growth plate cartilage chondrocyte differentiation;growth plate cartilage chondrocyte proliferation;cGMP biosynthetic process;protein folding;receptor guanylyl cyclase signaling pathway;negative regulation of cell population proliferation;post-embryonic development;regulation of signaling receptor activity;positive regulation of cGMP-mediated signaling;cGMP-mediated signaling;reproductive process;negative regulation of collagen biosynthetic process;regulation of multicellular organism growth;response to ethanol;positive regulation of osteoblast differentiation;regulation of smooth muscle cell proliferation;negative regulation of meiotic cell cycle;positive regulation of blood vessel diameter;negative regulation of oocyte maturation;regulation of cardiac conduction;negative regulation of DNA biosynthetic process
- Cellular component
- extracellular region;extracellular space;secretory granule;protein-containing complex
- Molecular function
- signaling receptor binding;hormone activity;hormone receptor binding